Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-06

Clinical Trial Update: Nu-3 Gel for Infected Diabetic Foot Ulcers [Phase 2]

View source ↗

Summary

Nu-3 Gel is being evaluated in a Phase 2 trial for infected diabetic foot ulcers, and the study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nu-3 Gel

Snippet

Sponsor: Lakewood-Amedex Inc | Conditions: Diabetic Foot Infection | Phase 2 | Status: NOT_YET_RECRUITING